Namo Kim MD, PhD et al
Canadian Journal of Anesthesia Nov 2026
Purpose
Remifentanil infusion titrated to effect-site concentration (Ce) is commonly used to suppress coughing during emergence from general anesthesia; nevertheless, the optimal Ce range remains unclear. We aimed to conduct a systematic review and meta-analysis to synthesize the existing evidence on the optimal Ce values of remifentanil for cough suppression during emergence.
Source
We performed a comprehensive literature search using PubMed®, Embase®, Web of Science™, the Cochrane Library, and Google Scholar on 27 February 2025. We included prospective studies that used the up-and-down method to estimate the effective concentrations of remifentanil in 50% of patients (EC50) and 95% of patients (EC95) for suppressing coughing during emergence from general anesthesia with tracheal intubation in adult patients. We excluded studies in children or patients undergoing cardiac surgery, as well as those that only compared predefined Ce targets of remifentanil to determine optimal dosing. We obtained pooled estimates using a random-effects model with inverse-variance method, and heterogeneity was quantified using the I2 statistic. We assessed risk of bias using the Cochrane Risk-of-Bias 2 tool for randomized trials and the Methodological Index for Non-Randomized Studies for nonrandomized comparative or single-arm studies. The primary outcome was EC50 estimated using the up-and-down method, with secondary outcomes including model-based EC50 and EC95 estimates.
Principal findings
We included 22 prospective studies comprising 857 adult participants, and none were assessed as being at a high risk of bias or of low methodologic quality. Based on 28 groups and 653 participants across 17 studies, the pooled mean EC50 from the up-and-down method was 2.0 ng·mL−1 (95% confidence interval [CI], 1.8 to 2.3), with considerable heterogeneity (I2 = 74.5%). Based on 29 groups and 693 participants across 18 studies, the model-based EC50 was 1.9 ng·mL−1 (95% CI, 1.6 to 2.1), with considerable heterogeneity (I2 = 96.1%). Based on 31 groups and 809 participants across 20 studies, the model-based EC95 was 2.7 ng·mL−1 (95% CI, 2.5 to 3.0), with considerable heterogeneity (I2 = 99.5%). Subgroup analyses revealed higher mean EC50 values in male individuals (2.6 ng·mL−1) and the highest mean EC50 in patients undergoing video-assisted thoracic surgery (2.6 ng·mL−1). Using the Grading of Recommendations, Assessment, Development, and Evaluation framework, the certainty of evidence was rated as very low for all outcomes.
Conclusions
The identified EC50 and EC95 values of remifentanil for suppressing coughing during emergence from general anesthesia in adults were 2.0 and 2.7 ng·mL−1, respectively. Patient sex and surgical type may influence the required Ce. Careful dose adjustment is recommended to avoid delayed awakening and hypoventilation, especially in cases requiring higher concentrations.